The National Institute on Aging (NIA), part of the National Institutes of Health, today announced that it has committed more than $36.7 million over the next five years to support and expand its Centers on the Demography and Economics of Aging. The Centers form a network of universities and organizations leading innovative studies on the characteristics of the aging population.
The Massachusetts General Hospital (MGH)'s Multicultural Affairs Office and the Executive Committee on Research are inviting basic, clinical, translational and health services investigators to apply for its 2010 Physician-Scientist Development Award designed for MD and/or PhD investigators at MGH who are under-represented in academic medicine.
The award is intended to provide transitional funding for support in the development of such physicians/scientists, and an amount of $30,000 per year, plus 15% indirect costs will be provided for each awardee.
Sharon K. Inouye, MD, MPH, director of the Aging Brain Center at the Institute for Aging Research of Hebrew SeniorLife, has received the Boston Chamber of Commerce's 2010 Pinnacle Award for Achievement in the Professions.
MD and PhD investigators in either basic or clinical research at the Massachusetts General Hospital are encouraged to apply for fellowship awards from the MGH Executive Committee on Research (ECOR) Fund for Medical Discovery.
Each award, unrestricted as to area of study, includes a stipend of $40,000, plus applicable fringe benefits and 15% indirect costs, and are effective on or about September 1, 2010. The application deadline for the fellowship award is 3:00pm on February 10, 2010.
More information regarding eligibility and application information is attached.
Harvard Catalyst is a pan-University collaborative effort committed to harnessing the human, technological, and fiscal resources of Harvard and its Academic Healthcare Centers (AHCs) to reduce the burden of human illness. To foster cross-institutional and cross-disciplinary collaboration, Harvard Catalyst offers seed funds in the form of Pilot Grants.
Harvard Catalyst has funded two rounds of Pilot Grants. The window for submitting a Pilot Grant application for Year 3 will start on December 3, 2009.
Dr. Lewis Lipsitz: Geriatrics is still one of the frontiers of medicine, since it's really only recently that people have begun experiencing old age - a century ago, the average life expectancy was 47, and today, it's well over 80. So it's exciting to be in a field on the cutting edge.
What did you find most rewarding about it?
Dr. LL: Old people are fun! They have a wonderful amount of history, great stories to tell, and a wide breath of experience that teaches me every day.
The Massachusetts ADRC and the Harvard NeuroDiscovery Center have joined forces to fund the best novel ideas for pilot projects aimed at understanding and developing treatments for neurodegenerative diseases. Together, we are pleased to announce a joint call for pilot study applications from investigators within the Harvard community. Grants with a dollar value up to $30,000 (direct costs) will be awarded for the duration of one-year. A total of $240,000 is available.
The Program on the Global Demography of Aging at the Harvard School of Public Health funds pilot project grants in the area of the Economics and Demography of Aging. The aim is to provide assistance to Harvard faculty in undertaking preliminary research that may subsequently lead to a larger research project. The PGDA is a center for research on the Economics and Demography of Aging funded by the by the National Institute of Aging.
The objective of The Ellison Medical Foundation (www.ellisonfoundation.org) New Scholars Program is to support new investigators of outstanding promise in the basic biological sciences relevant to understanding lifespan development processes and age-related diseases and disabilities. The award is intended to provide significant support to new investigators needed to permit them to become established in the field of aging.
Jack Szostak, a genetics professor at Harvard Medical School and Harvard-affiliated Massachusetts General Hospital, has won the 2009 Nobel Prize in physiology or medicine for pioneering work in the discovery of telomerase, an enzyme that protects chromosomes from degrading.
The work not only revealed a key cellular function, it also illuminated processes involved in disease and aging.